Clinical trial
Mid-term Survival of the Insignia Stem in Primary Total Hip Arthroplasty
NCT05313321 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mid-term Survival of the Insignia Stem in Primary Total Hip Arthroplasty
- Lead sponsor
- University of Utah
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 17, 2022
- Completion date
- March 31, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary total hip arthroplasty